Customer survey confirms strong symptom relief among VagiVital® users
Stockholm, 28th January, 2019 – Peptonic Medical (publ) (“Peptonic” or “Company”) today announced that the results of a recently conducted survey among women that have used VagiVital® indicate a very strong treatment effect. Of more than two hundered respondents of the survey, three out of four reported symptom relief, regardless for how long they had used VagiVital®. Of those women who had used VagiVital® for two months or longer, nine out of ten reported symptom relief.The survey was performed during the period of December 2018 to mid January 2019. - These results are of course